Monday, August 11, 2003 1:12:02 PM
It was the starting point.
The premise of the originating post was that if 'big pharma' wanted DNAP's technology they would just take it. As far as I know the only things protecting DNAP's rights to their intellectual property are the patent applications.
As the post stated, big pharma could take the technology and modify it slightly to bypass the patent or could simply overwhelm a small company in court.
A patent battle would be DNAP's only defense against such a move and would be potentially disastrous.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM